Lorlatinib for advanced anaplastic lymphoma kinase–positive non–small cell lung cancer: Results of the IFCT-1803 LORLATU cohort

Simon Baldacci, Benjamin Besse, Virginie Avrillon, B. Mennecier, Julien Mazières, Pascale Dubray‐Longeras, Alexis B. Cortot, R. Descourt, H. Doubre, Xavier Quantin, M. Duruisseaux, I. Monnet, Denis Moro‐Sibilot, Jacques Cadranel, Christelle Clément-Duchêne, Sophie Cousin, Charles Ricordel, P. Merle, Josiane Otto, S. Schneider, Alexandra Langlais, Franck Morin, Virginie Westeel, Nicolas Girard